Skip to main content
. 2012 Jul 11;2012(7):CD002991. doi: 10.1002/14651858.CD002991.pub3

2.1. Analysis.

2.1

Comparison 2 ICS versus placebo, parallel‐group studies, greater than 2 months to 6 months (all doses), Outcome 1 Change in pre‐bronchodilator FEV1 compared with baseline.